Related Experiment Video
Updated: Mar 30, 2026

A Multiplex Serological Assay for the Detection of Antibody Responses to Arboviruses
Published on: November 4, 2025
Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004-2013
Clément Lingani1, Cassi Bergeron-Caron2, James M Stuart3
1Inter-country Support Team for West Africa, World Health Organization, Ouagadougou, Burkina Faso.
Background:
An enhanced meningitis surveillance network was established across the meningitis belt of sub-Saharan Africa in 2003 to rapidly collect, disseminate, and use district weekly data on meningitis incidence. Following 10 years' experience with enhanced surveillance that included the introduction of a group A meningococcal conjugate vaccine, PsA-TT (MenAfriVac), in 2010, we analyzed the data on meningitis incidence and case fatality from countries reporting to the network.
Methods:
After de-duplication and reconciliation, data were extracted from the surveillance bulletins and the central database held by the World Health Organization Inter-country Support Team in Burkina Faso for countries reporting consistently from 2004 through 2013 (Benin, Burkina Faso, Chad, Democratic Republic of Congo, Ghana, Côte d'Ivoire, Mali, Niger, Nigeria, Togo).
Results:
The 10 study countries reported 341 562 suspected and confirmed cases over the 10-year study period, with a marked peak in 2009 due to a large epidemic of group A Neisseria meningitidis (NmA) meningitis. Case fatality was lowest (5.9%) during this year. A mean of 71 and 67 districts annually crossed the alert and epidemic thresholds, respectively. The incidence rate of NmA meningitis fell >10-fold, from 0.27 per 100,000 in 2004-2010 to 0.02 per 100,000 in 2011-2013 (P < .0001).
Conclusions:
In addition to supporting timely outbreak response, the enhanced meningitis surveillance system provides a global overview of the epidemiology of meningitis in the region, despite limitations in data quality and completeness. This study confirms a dramatic fall in NmA incidence after the introduction of PsA-TT.
Insights
The enhanced meningitis surveillance system in Africa significantly reduced group A bacterial meningitis cases after the 2010 vaccine introduction. This system provides crucial epidemiological data for outbreak response and disease monitoring.
Area of Science:
- Epidemiology
- Infectious Disease Surveillance
- Vaccinology
Background:
- Enhanced meningitis surveillance network established in sub-Saharan Africa in 2003.
- Network collects, disseminates, and utilizes district-level weekly meningitis incidence data.
- 10 years of data analyzed, including introduction of the group A meningococcal conjugate vaccine, PsA-TT (MenAfriVac), in 2010.
Purpose of the Study:
- Analyze 10 years of meningitis incidence and case fatality data from the enhanced surveillance network.
- Evaluate the impact of the PsA-TT vaccine on meningitis epidemiology in the region.
- Assess the utility of the surveillance system for outbreak response and epidemiological overview.
Main Methods:
- Data extracted from surveillance bulletins and WHO database for 10 consistently reporting countries (2004-2013).
- Data de-duplicated and reconciled.
- Analysis focused on meningitis incidence and case fatality rates, particularly for Neisseria meningitidis serogroup A (NmA).
Main Results:
- 341,562 suspected/confirmed cases reported over 10 years, with a peak in 2009 due to NmA meningitis.
- Case fatality rate was lowest (5.9%) during the 2009 epidemic year.
- NmA meningitis incidence rate decreased over 10-fold, from 0.27 to 0.02 per 100,000 between 2004-2010 and 2011-2013, respectively (P < .0001).
Conclusions:
- The enhanced meningitis surveillance system effectively supports timely outbreak response.
- The system provides a valuable global overview of meningitis epidemiology in the region, despite data limitations.
- A dramatic reduction in NmA meningitis incidence was confirmed following the introduction of the PsA-TT vaccine.
Related Concept Videos
Viral Meningitis
Principles of Disease Surveillance
Arboviral Encephalitis

